Cargando…
Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway
Gastric cancer (GC) is among the five most common malignancies worldwide. Traditional chemotherapy cannot efficiently treat the disease and faces the problems of side effects and chemoresistance. Polygoni orientalis Fructus (POF), with flavonoids as the main bioactive compounds, exerts anti-cancer p...
Autores principales: | Shan, Hui, Zhang, Xin, Mi, Yalu, Jia, Jihui, Wang, Bo, Yang, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788236/ https://www.ncbi.nlm.nih.gov/pubmed/36558929 http://dx.doi.org/10.3390/ph15121477 |
Ejemplares similares
-
Effect of Eriodictyol on Retinoblastoma via the PI3K/Akt Pathway
por: Wen, Shu, et al.
Publicado: (2021) -
Retracted: Effect of Eriodictyol on Retinoblastoma via the PI3K/Akt Pathway
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Eriodictyol Inhibits Proliferation, Metastasis and Induces Apoptosis of Glioma Cells via PI3K/Akt/NF-κB Signaling Pathway
por: Li, Wenjun, et al.
Publicado: (2020) -
Eriodictyol Alleviated LPS/D-GalN-Induced Acute Liver Injury by Inhibiting Oxidative Stress and Cell Apoptosis via PI3K/AKT Signaling Pathway
por: Zheng, Xiaomei, et al.
Publicado: (2023) -
Effect of Eriodictyol on Collagen-Induced Arthritis in Rats by Akt/HIF-1α Pathway
por: Lei, ZhongHua, et al.
Publicado: (2020)